InMode (INMD) Capital Expenditures (2018 - 2026)
InMode (INMD) posted quarterly Capital Expenditures of -$172000.0 for Q1 2026, down 102.35% year-on-year from $7.3 million in Q1 2025, and up 67.79% on a QoQ basis from -$534000.0 in Q4 2025.
InMode (INMD) Capital Expenditures (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Capital Expenditures for 9 consecutive years, with -$172000.0 the latest figure, recorded in Q1 2026.
- Quarterly Capital Expenditures fell 102.35% year-over-year to -$172000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 64.95% YoY) and the FY2025 annual result came in at -$972000.0, down 45.29% from the prior year.
- Capital Expenditures climbed to -$172000.0 in Q1 2026 per INMD's latest filing, from -$534000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for INMD reached as high as -$21000.0 in Q4 2023 and fell as low as -$561000.0 in Q2 2022.
- A 5-year average of -$240764.7 and a median of -$219000.0 in 2025 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures jumped 93.6% — and 2024, when it slumped 1014.29%.
- Year by year, Capital Expenditures stood at -$328000.0 in 2022, then soared by 93.6% to -$21000.0 in 2023, then sank by 1014.29% to -$234000.0 in 2024, then tumbled by 128.21% to -$534000.0 in 2025, then jumped by 67.79% to -$172000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$172000.0, -$534000.0, and -$134000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | -172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172,000.00 |
| Mar 31, 2026 | -172,000.00 |
| Dec 31, 2025 | -534,000.00 |
| Dec 31, 2025 | -534,000.00 |
| Sep 30, 2025 | -134,000.00 |
| Sep 30, 2025 | -134,000.00 |
| Jun 30, 2025 | -219,000.00 |
| Jun 30, 2025 | -219,000.00 |
| Mar 31, 2025 | -85,000.00 |
| Mar 31, 2025 | -85,000.00 |
| Dec 31, 2024 | -234,000.00 |
| Dec 31, 2024 | -234,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -246,000.00 |
| Jun 30, 2024 | -246,000.00 |
| Mar 31, 2024 | -112,000.00 |
| Mar 31, 2024 | -112,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Dec 31, 2023 | -21,000.00 |